Related Experiment Video
Updated: Dec 25, 2025
02:21
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
1.2K
High-flow post-traumatic priapism: diagnostic and therapeutic workup
Ciro Acampora1,2, Antonio Borzelli1,2, Marco Di Serafino3,4
1Department of General and Emergency Radiology, "Antonio Cardarelli" Hospital, Antonio Cardarelli St 9, 80131, Naples, Italy.
Journal of Ultrasound
|March 22, 2020
Summary
High-flow priapism, a rare condition from perineal trauma, involves prolonged erections. Digital subtraction angiography is the gold standard for managing this arterio-cavernosal fistula.
Area of Science:
- Urology
- Radiology
- Trauma Surgery
Background:
- Priapism is defined as a prolonged penile erection lasting over 6 hours without sexual stimulation.
- High-flow priapism is a rare subtype typically resulting from perineal trauma causing an arterio-cavernosal fistula.
Observation:
- This case report details a young male patient who developed high-flow priapism following blunt perineal trauma from a motorcycle accident.
- Specific diagnostic findings using color Doppler ultrasound were meticulously examined.
Findings:
- Color Doppler ultrasound is crucial for diagnosing high-flow priapism by visualizing the arterio-cavernosal fistula.
- Digital subtraction angiography (DSA) is confirmed as the gold standard for both diagnosis and guiding therapeutic management.
Implications:
- This case highlights the importance of recognizing high-flow priapism after trauma.
- Accurate diagnosis via ultrasound and angiography is essential for effective treatment and preventing complications.
- Understanding the specific ultrasound characteristics aids in timely intervention for traumatic priapism.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
211
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
211
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
454
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
454
01:30Acute Coronary Syndrome III: Diagnostic Studies
150
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
150
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
381
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
381
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
379
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
379
01:27Peripheral Artery Disease III: Interprofessional Care
182
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
182